Mabqi contributed to the article « Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis » published in the journal Nature Communications on August 31, 2023.
Mabqi is proud to have contributed to the article « Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis » published in the journal Nature Communications on August 31, 2023.
This study was conducted in collaboration with Laboratoires Servier. You can access the article by clicking on this link.
